GURU RAMANATHAN - Corporate Board Profile

NATURAL ALTERNATIVES INTERNATIONAL INC

Filing Date	Source Excerpt
2021-10-28	Dr. Ramanathan was appointed to a vacant seat on the Board, and was also appointed to the Audit, Human Resources and Nominating Committees of the Board on September 17, 2021. Dr. Ramanathan was appointed to the Board on September 17, 2021 and did not receive any compensation for the year ended June 30, 2021.
2022-10-25	Dr. Ramanathan was appointed to a vacant seat on the Board, and was also appointed to the Audit, Human Resources and Nominating Committees of the Board on September 17, 2021. Each of the non-employee directors (Messrs. Dunn and Ramanathan, and Ms. Matherly) receive an annual retention fee of $10,000, and a fee of $1,000 for each board of directors meeting and each committee of the board of directors meeting such director attends. The table below provides information about the compensation of our currently sitting non-employee directors during the fiscal year ended June 30, 2022. Guru Ramanathan: $115,420.
2023-10-26	Dr. Ramanathan was appointed to a vacant seat on the Board, and was also appointed to the Audit, Human Resources and Nominating Committees of the Board on September 17, 2021. He is President of Global Healthcare Innovation Advisory Services company, currently serving on Corporate and Advisory Board’s for established and early-stage companies in Global Food, Nutrition, Pharma, OTC, Digital Health and Primary Care Medicine industry sectors. He is very active in Nutrition Industry initiatives having been a founding member and current Chairman of the ‘Supplement Safety & Compliance Initiative’ (SSCI). He currently serves on CRN’s OWL Registry advisory board, as well as the Southwest College of Naturopathic Medicine’s Advisory Board. Dr. Ramanathan is an Adjunct Professor at Pennington Biomedical Research Center in Baton Rouge Louisiana. Dr. Ramanathan is a globally recognized expert on Innovation Management and his advisory concentrations include Scientific Affairs, Regulatory Compliance, Quality Assurance and Control, Clinical Trials Design & Management, Technology Acquisition, Alliance Management, Product Development and Manufacturing in the Global Health and Wellness Industry. Dr. Ramanathan’s industry experience spans Clinical care, Pharma, Consumer health, Animal health and the Retail sectors. His most recent appointment was with Pittsburgh based General Nutrition Corporation (GNC) as its Chief Innovation Officer, Senior Vice President and Member of the Executive Committee. Prior to that Dr. Ramanathan was a Senior Director for the US subsidiaries of Nutricia (Danone). Before this he was Medical Director for the US subsidiary of Scotia Pharmaceuticals. He has also held various industry consulting, research and teaching appointments in India and the US. Dr. Ramanathan holds an MBA from Duke University’s Fuqua School of Business focused on global business practices. He earned his Ph.D. from Tufts University in Healthcare Innovation Management. Each of the non-employee directors (Messrs. Dunn and Ramanathan, and Ms. Matherly) receive an annual retention fee of $10,000, and a fee of $1,000 for each board of directors meeting and each committee of the board of directors meeting such director attends. The table below provides information about the compensation of our currently sitting non-employee directors during the fiscal year ended June 30, 2023. DIRECTOR COMPENSATION TABLE FOR FISCAL-YEAR ENDED JUNE 30, 2023 Guru Ramanathan 22,000 62,020 37,000 — 121,020
2024-10-23	Dr. Ramanathan was appointed to a vacant seat on the Board, and was also appointed to the Audit, Human Resources and Nominating Committees of the Board on September 17, 2021. Each of the non-employee directors (Messrs. Dunn and Ramanathan, and Ms. Matherly) receive an annual retention fee of $10,000, and a fee of $1,000 for each board of directors meeting and each committee of the board of directors meeting the director attends. The table below provides information about the compensation of our currently sitting non-employee directors during the fiscal year ended June 30, 2024. Guru Ramanathan: Total ($) 122,000.